Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
14.42
+0.17 (1.19%)
Feb 3, 2026, 3:00 PM CST
SHA:600557 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 2,157 | 2,195 | 1,979 | 1,601 | 937.44 | 768.81 |
Trading Asset Securities | - | 40 | 460 | 170 | 176 | 4.5 |
Cash & Short-Term Investments | 2,157 | 2,235 | 2,439 | 1,771 | 1,113 | 773.31 |
Cash Growth | 0.73% | -8.36% | 37.70% | 59.08% | 43.98% | 89.05% |
Accounts Receivable | 630.91 | 700.54 | 1,092 | 1,471 | 1,350 | 1,616 |
Other Receivables | 3.3 | 6.33 | 5.48 | 9.67 | 11.75 | 9.82 |
Receivables | 634.21 | 706.87 | 1,098 | 1,480 | 1,362 | 1,626 |
Inventory | 445.23 | 540.27 | 350.11 | 342.82 | 338.08 | 376.53 |
Other Current Assets | 64.82 | 113.69 | 188.65 | 135.32 | 60.91 | 110.3 |
Total Current Assets | 3,302 | 3,596 | 4,076 | 3,730 | 2,874 | 2,886 |
Property, Plant & Equipment | 2,891 | 2,752 | 2,539 | 2,508 | 2,533 | 2,557 |
Long-Term Investments | 11.33 | 15.34 | 15.32 | 45.61 | 60.64 | 73.63 |
Goodwill | 58.99 | 58.99 | 58.99 | 58.99 | 58.99 | 58.99 |
Other Intangible Assets | 203.62 | 171.46 | 198.17 | 231.15 | 282.73 | 340.79 |
Long-Term Deferred Tax Assets | 47.71 | 45.31 | 46.22 | 15.96 | 16.77 | 17.68 |
Long-Term Deferred Charges | 202.96 | 203.84 | 192.67 | 184.79 | 171.14 | 164.69 |
Other Long-Term Assets | 22.99 | 64.4 | 62.81 | 21.63 | 20.72 | 20.14 |
Total Assets | 6,740 | 6,907 | 7,189 | 6,796 | 6,018 | 6,119 |
Accounts Payable | 210.33 | 226.87 | 236.61 | 373.36 | 359.75 | 281 |
Accrued Expenses | 20.32 | 880.74 | 1,030 | 814.57 | 531.14 | 528.47 |
Short-Term Debt | - | - | - | - | 234.5 | 488 |
Current Income Taxes Payable | 60.65 | 2.14 | 2.42 | 2.1 | 2.05 | 5.33 |
Current Unearned Revenue | 22.83 | 25.46 | 25.17 | 214.87 | 25.34 | 26.5 |
Other Current Liabilities | 1,338 | 909.27 | 748.41 | 376.2 | 300.08 | 366.75 |
Total Current Liabilities | 1,652 | 2,044 | 2,042 | 1,781 | 1,453 | 1,696 |
Long-Term Debt | 1.93 | 1.93 | 1.93 | 1.93 | 1.93 | 1.93 |
Long-Term Unearned Revenue | 172.56 | 155.27 | 126.16 | 78.78 | 90.52 | 93.81 |
Total Liabilities | 1,827 | 2,202 | 2,171 | 1,862 | 1,545 | 1,792 |
Common Stock | 566.16 | 581.8 | 584.75 | 584.6 | 592.88 | 592.88 |
Additional Paid-In Capital | - | - | 178.29 | 98.13 | 171.79 | 174.57 |
Retained Earnings | 4,148 | 4,145 | 4,225 | 4,136 | 3,720 | 3,399 |
Treasury Stock | - | -211.98 | -48.14 | -64.7 | -180 | - |
Total Common Equity | 4,714 | 4,515 | 4,940 | 4,754 | 4,304 | 4,167 |
Minority Interest | 198.57 | 190.51 | 78.47 | 179.8 | 168.35 | 160.13 |
Shareholders' Equity | 4,913 | 4,705 | 5,019 | 4,934 | 4,473 | 4,327 |
Total Liabilities & Equity | 6,740 | 6,907 | 7,189 | 6,796 | 6,018 | 6,119 |
Total Debt | 2.97 | 1.93 | 1.93 | 1.93 | 236.43 | 489.93 |
Net Cash (Debt) | 2,154 | 2,233 | 2,437 | 1,769 | 877.01 | 283.39 |
Net Cash Growth | 0.68% | -8.37% | 37.74% | 101.75% | 209.48% | - |
Net Cash Per Share | 3.76 | 3.88 | 4.20 | 3.05 | 1.53 | 0.47 |
Filing Date Shares Outstanding | 566.16 | 569.46 | 583.9 | 594.68 | 576.43 | 592.88 |
Total Common Shares Outstanding | 566.16 | 569.46 | 583.9 | 594.68 | 576.43 | 592.88 |
Working Capital | 1,649 | 1,551 | 2,033 | 1,949 | 1,421 | 1,190 |
Book Value Per Share | 8.33 | 7.93 | 8.46 | 7.99 | 7.47 | 7.03 |
Tangible Book Value | 4,452 | 4,284 | 4,683 | 4,464 | 3,963 | 3,767 |
Tangible Book Value Per Share | 7.86 | 7.52 | 8.02 | 7.51 | 6.87 | 6.35 |
Buildings | - | 2,483 | 2,402 | 2,460 | 2,398 | 2,385 |
Machinery | - | 1,340 | 1,318 | 1,233 | 1,191 | 1,162 |
Construction In Progress | - | 472.81 | 227.25 | 98.54 | 82.9 | 14.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.